September 3rd 2024
We are proud to announce the appointment of Stephane Argivier as our new Chief Executive Officer, effective from 1st September 2024. Stephane Argivier will lead the next stage in the company’s expansion.
)
January 11th 2021
From the outset of the COVID-19 outbreak, testing for SARS-CoV-2 has been a priority. Initially just having a test for COVID-19 was a scientific success, enabled by the publication of the first viral genomic sequence in January 2020. Here we highlight some of the key testing events that have taken place, and their outcomes.
)
August 5th 2020
Two types of tests for SARS-CoV-2 currently predominate. The first are molecular tests, based on PCR technology, that detect the presence of viral nucleic acid and therefore indicate a current infection. The second are serology tests.
)
May 20th 2019
Irregular antibodies are antibodies found in the blood of transfusion donors that have the potential to cause hemolysis of the recipient blood. Screening using an indirect Coombs Test should be performed to ensure that the donor blood is compatible with the recipient.
)